Multiarm high-throughput integration site detection: Limitations of LAM-PCR technology and optimization for clonal analysis

Stem Cells and Development

Volumn 16, Issue 3, 2007, Pages 381-392

  Harkey, Michael A ^a   Kaul, Rajinder ^b   Jacobs, Michael A ^b   Kurre, Peter ^c   Bovee, Don ^b   Levy, Ruth ^b   Blau, C Anthony ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CLONE; CONTROLLED STUDY; GENE AMPLIFICATION; LINEAR AMPLIFICATION POLYMERASE CHAIN REACTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; RETROVIRUS; VIRUS DNA CELL DNA INTERACTION;

ANIMALS; CELL SEPARATION; CLONE CELLS; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; MICE; NIH 3T3 CELLS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RETROVIRIDAE; SENSITIVITY AND SPECIFICITY;

EID: 34347337597     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.0015     Document Type: Article

References (27)

1. Schmidt M, G Hoffmann, M Wissler, N Lemke, A Mussig, H Glimm, DA Williams, S Ragg, CU Hesemann and C von Kalle. (2001). Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum Gene Ther 12:743-749.
2. Schmidt M, P Zickler, G Hoffmann, S Haas, M Wissler, A Muessig, JF Tisdale, K Kuramoto, RG Andrews, T Wu, H-P Kiem, CE Dunbar and C von Kalle. (2002). Polyclonal long-term repopulating stem cell clones in a primate model. Blood 100:2737-2743.
3. Lund AH, M Duch and FS Pedersen. (1996). Transcriptional silencing of retroviral vectors. J Biomed Sci 3:365-378.
4. + baboon repopulating cells. Blood 102:3117-3119.
5. Ellis J. (2005). Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum Gene Ther 16:1241-1246.
6. Nagayama J, M Iino, Y Tada, H Kusaba, A Kiue, K Ohshima, M Kuwano and M Wada. (2001). Retrovirus insertion and transcriptional activation of the multidrug-resistance gene in leukemias treated by a chemotherapeutic agent in vivo. Blood 97:759-766.
7. Bedigian HG, DA Johnson, NA Jenkins, NG Copeland and R Evans. (1984). Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice. J Virol 51:586-594.
8. Gilbert DJ, PE Neumann, BA Taylor, NA Jenkins and NG Copeland. (1993). Susceptibility of AKXD recombinant inbred mouse strains to lymphomas. J Virol 67:2083-2090.
9. Li Z, J Dullmann, B Schiedlmeier, M Schmidt, C von Kalle, J Meyer, M Forster, C Stocking, A Wahlers, O Frank, W Ostertag, K Kuhlcke, HG Eckert, B Fehse and C Baum. (2002). Murine leukemia induced by retroviral gene marking. Science 296:497.
10. Hacein-Bey-Abina S, C von Kalle, M Schmidt, MP McCormack, N Wulffraat, P Leboulch, A Lim, CS Osborne, R Pawliuk, E Morillon, R Sorensen, A Forster, P Fraser, JI Cohen, G de Saint Basile, I Alexander, U Wintergerst, T Frebourg, A Aurias, D Stoppa-Lyonnet, S Romana, I Radford-Weiss, F Gross, F Valensi, E Delabesse, E Macintyre, F Sigaux, J Soulier, LE Leiva, M Wissler, C Prinz, TH Rabbitts, F Le Deist, A Fischer and M Cavazzana-Calvo. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-419.
11. Taruscio D and L Manuelidis. (1991). Integration site preferences of endogenous retroviruses. Chromosoma 101:141-156.
12. Holmes-Son ML, RS Appa and SA Chow. (2001). Molecular genetics and target site specificity of retroviral integration (review). Adv Gen 43:33-69.
13. Bushman FD. (2002). Integration site selection by lentiviruses: biology and possible control (review). Curr Topics Microbiol Immunol 261:165-177.
14. Schroder AR, P Shinn, H Chen, C Berry, JR Ecker and F Bushman. (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110:521-529.
15. Wu X, Y Li, B Crise and SM Burgess. (2003). Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749-1751.
16. Laufs S, B Gentner, KZ Nagy, A Jauch, A Benner, S Naundorf, K Kuehlcke, B Schiedlmeier, AD Ho, WJ Zeller and S Fruehauf. (2003). Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells. Blood 101:2191-2198.
17. Imren S, ME Fabry, KA Westerman, R Pawliuk, P Tang, PM Rosten, RL Nagel, P Leboulch, CJ Eaves and RK Humphries. (2004). High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells. J Clin Invest 114:953-962.
18. Johnson CN and LS Levy. (2005). Matrix attachment regions as targets for retroviral integration. Virol J 2:68.
19. Kuramoto K, D Follman, P Hematti, S Sellers, MO Laukkanen, R Seggewiss, ME Metzger, A Krouse, RE Donahue, C von Kalle and CE Dunbar. (2004). The impact of low-dose busulfan on clonal dynamics in nonhuman primates. Blood 104:1273-1280.
20. Kiem H-P, S Sellers, B Thomasson, JC Morris, JF Tisdale, PA Horn, P Hematti, R Adler, K Kuramoto, B Calmels, A Bonifacino, J Hu, C von Kalle, M Schmidt, B Sorrentino, A Nienhuis, CA Blau, RG Andrews, RE Donahue and CE Dunbar. (2004). Long-term clinical and molecular followup of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia. Mol Ther 9:389-395.
21. Schmidt M, DA Carbonaro, C Speckmann, M Wissler, J Bohnsack, M Elder, BJ Aronow, JA Nolta, DB Kohn and C von Kalle. (2003). Clonality analysis after retroviral-mediated gene transfer to CD34(+) cells from the cord blood of ADA-deficient SCID neonates. Nature Med 9:463-468.
22. Podsakoff GM, BC Engel, DA Carbonaro, C Choi, EM Smogorzewska, G Bauer, D Selander, S Csik, K Wilson, MR Betts, RA Koup, GJ Nabel, K Bishop, S King, M Schmidt, C von Kalle, JA Church and DB Kohn. (2005). Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34(+) cells. Mol Ther 12:77-86.
23. Neff T, BC Beard, LJ Peterson, P Anandakumar, J Thompson and H-P Kiem. (2005). Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy. Blood 105:997-1002.
24. Kurre P, P Anandakumar, MA Harkey, B Thomasson and H-P Kiem. (2004). Efficient marking of murine long-term repopulating stem cells targeting unseparated marrow cells at low lentiviral vector particle concentration. Mol Ther 9:914-922.
25. Miller DG, GD Trobridge, LM Petek, MA Jacobs, R Kaul and DW Russell. (2005). Large-scale analysis of adeno-associated virus vector integration sites in normal human cells. J Virol 79:11434-11442.
26. Modlich U, OS Kustikova, M Schmidt, C Rudolph, J Meyer, Z Li, K Kamino, N von Neuhoff, B Schlegelberger, K Kuehlcke, KD Bunting, S Schmidt, A Deichmann, C von Kalle, B Fehse and C Baum. (2005). Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis. Blood 105:4235-4246.
27. Kustikova O, B Fehse, U Modlich, M Yang, J Dullmann, K Kamino, N von Neuhoff, B Schlegelberger, Z Li and C Baum. (2005). Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308:1171-1174.